Cancer multi-omics data has greatly expanded over recent decades, surpassing the human ability to extract meaningful information. The successful implementation of artificial intelligence systems into clinical pipelines to interpret complex datasets, and improve the outcomes of patients with cancer, demands strong validation using real-world evidence while also being mindful of ethical and social aspects.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Digital pathology-based artificial intelligence models for differential diagnosis and prognosis of sporadic odontogenic keratocysts
International Journal of Oral Science Open Access 26 February 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 digital issues and online access to articles
$119.00 per year
only $9.92 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Berry, S. et al. Science 372, eaba2609 (2021).
Aboutalib, S. S. et al. Clin. Cancer Res. 24, 5902–5909 (2018).
McKinney, S. M. et al. Nature 577, 89–94 (2020).
Hiremath, A. et al. Lancet Digit. Health 3, e445–e454 (2021).
Yala, A. et al. Sci. Transl. Med. 13, eaba4373 (2021).
McIntosh, C. et al. Nat. Med. 27, 999–1005 (2021).
Lehman, C. D. et al. JAMA Intern. Med. 175, 1828–1837 (2015).
Lotter, W. et al. Nat. Med. 27, 244–249 (2021).
Freeman, K. et al. BMJ 374, n1872 (2021).
Buolamwini, J. & Gebru, T. Proc. Mach. Learn. Res. 81, 77–91 (2018).
Bridge to Artificial Intelligence (Bridge2AI) (NIH, 2021); https://commonfund.nih.gov/bridge2ai
Kaushal, A., Altman, R. & Langlotz, C. JAMA 324, 1212–1213 (2020).
Rieke, N. et al. NPJ Digit. Med. 3, 119 (2020).
Steiner, D. F. et al. JAMA Netw. Open 3, e2023267 (2020).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
C.D.L. receives institutional grant/research support from the Breast Cancer Research Foundation, National Cancer Institute, GE Healthcare, Inc. and Hologic, Inc. and is co-founder of Clairity, Inc. S.W. is a scientific consultant and stockholder of COGNISTX, Inc. S.W. receives research grants from the National Cancer Institute, National Institute of Biomedical Imaging and Bioengineering, National Science Foundation, Radiological Society of North America, UPMC Hillman Cancer Center and Amazon.
Rights and permissions
About this article
Cite this article
Lehman, C.D., Wu, S. Stargazing through the lens of AI in clinical oncology. Nat Cancer 2, 1265–1267 (2021). https://doi.org/10.1038/s43018-021-00307-4
Published:
Issue Date:
DOI: https://doi.org/10.1038/s43018-021-00307-4
This article is cited by
-
Digital pathology-based artificial intelligence models for differential diagnosis and prognosis of sporadic odontogenic keratocysts
International Journal of Oral Science (2024)
-
It’s a wrap for 2021!
Nature Cancer (2021)